Sbanken ASA
We hereby invite you to participate at the presentation of the Sbanken ASA's Q4 2020 report on Thursday 11 February at 12.00 CET.
Quarterly Earnings Release: Thursday 11 February 2021 at 07.00 CET.
Interim report and presentation material will be released and made available on the investor relations pages at https://sbanken.no/ir.
Results presentation:
Time: Thursday 11 February 2021 at 12.00 CET
Location: webcast
The presentation will be webcasted live at:
https://channel.royalcast.com/landingpage/hegnarmedia/20210211_7/
The presentation will be held in English by CEO Øyvind Thomassen and CFO Henning Nordgulen. A recording of the presentation will be available on our website shortly after the live webcast has ended.
Questions from investors and analysts will be addressed after the presentation. Should you wish to ask questions, please reach out to receive details.
For further information, please contact:
Jesper Hatletveit, Head of IR, +47 959 40 045
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Signify25.4.2025 07:05:00 CEST | Press release
Signify delivers update on CEO succession process; CFO Željko Kosanović appointed interim CEO
Avance Gas Holding Ltd25.4.2025 07:01:00 CEST | Press release
Avance Gas Holding Ltd: First Quarter 2025 Earnings Release
WithSecure Oyj25.4.2025 07:00:00 CEST | Press release
WithSecure Interim Report 1 January – 31 March 2025: Elements ARR growth continued, 70% ARR growth for Cloud Protection for Salesforce
Kitron ASA25.4.2025 07:00:00 CEST | Press release
Kitron: Ex dividend NOK 0.35 today
F. Hoffmann-La Roche Ltd25.4.2025 07:00:00 CEST | Press release
New England Journal of Medicine publishes phase III data showing single-dose Xofluza significantly reduces influenza virus transmission
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom